meso-2,3-Dibromosuccinic acid | CAS:608-36-6

We serve meso-2,3-Dibromosuccinic acid CAS:608-36-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
meso-2,3-Dibromosuccinic acid

Chemical Name:meso-2,3-Dibromosuccinic acid
CAS.NO:608-36-6
Synonyms:2,3-dibromobutanedioic acid
Molecular Formula:C4H4Br2O4
Molecular Weight:275.88000
 
Physical and Chemical Properties:
Density:2.486;
Melting point:275-290oC;
Boiling point:352oC;
Flash point:91oC;
 
Specification:
Appearance:White powder
Purity:≥98.0%
Moisture:≤0.1%
Residue on ignition:≤0.1%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As organic synthesis, pharmaceutical intermediates and soldering agents,an intermediate of 2,3-dimercaptosuccinic acid



Contact us for information like meso-2,3-Dibromosuccinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-dibromobutanedioic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,meso-2,3-Dibromosuccinic acid Use and application,meso-2,3-Dibromosuccinic acid technical grade,usp/ep/jp grade.


Related News: Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23.2,6-DIFLUOROBENZOTRIFLUORIDE manufacturer Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23.Ethyl 1-hydroxy-1H-1,2,3-triazole-4-carboxylate supplier Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.1-(benzotriazol-1-yl)octan-1-one vendor Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.The risk to the general public remains low. And we continue to be confident we are in a good position to respond to this developing situation.”